IOSP Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
473.6M
-3.6%
491.4M
+8.4%
453.2M
-0.5%
455.6M
+3.1%
441.9M
Cost of Revenue
344.5M
-2.4%
353.1M
+7.1%
329.7M
+0.5%
328.2M
+0.9%
325.2M
Gross Profit
129.1M
-6.7%
138.3M
+12.0%
123.5M
-3.1%
127.4M
+9.2%
116.7M
Operating Expenses
88.5M
-10.2%
98.6M
+7.5%
91.7M
+13.8%
80.6M
-37.3%
128.5M
R&D
16.8M
+18.3%
14.2M
+7.6%
13.2M
+20.0%
11.0M
-19.7%
13.7M
SG&A
71.7M
-14.9%
84.3M
+7.4%
78.5M
+13.3%
69.3M
-3.6%
71.9M
Operating Income
40.6M
+2.3%
39.7M
+24.8%
31.8M
-32.1%
46.8M
+496.6%
-11800000
EBITDA
50.2M
+1.0%
49.7M
+19.2%
41.7M
-25.8%
56.2M
+29.8%
43.3M
Net Income
31.6M
+1.3%
31.2M
+1.3%
30.8M
-35.0%
47.4M
+273.2%
12.7M
EPS (Basic)
$1.29
+3.2%
$1.25
+1.6%
$1.23
-35.6%
$1.91
+267.3%
$0.52
EPS (Diluted)
$1.29
+3.2%
$1.25
+2.5%
$1.22
-35.8%
$1.90
+265.4%
$0.52
Shares (Diluted)
24.7M
+0.1%
24.7M
-0.6%
24.8M
-0.3%
24.9M
+0.0%
24.9M
Innospec (IOSP) — Financials